跳至主要内容
临床试验/NCT03891316
NCT03891316已完成不适用

Human Biomonitoring of Operating Room Personnel With Occupational Exposure to the Volatile Anaesthetic Sevoflurane

Universitätsklinikum Hamburg-Eppendorf1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2019年3月11日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
1
主要终点
Urinary sevoflurane concentration (µg/l)

研究概览

简要总结

Sevoflurane is a widely used volatile agent for induction and maintenance of anaesthesia. The administration of sevoflurane involves the risk of occupational exposure. Possible negative implications of chronic occupational exposure to sevoflurane are not completely refuted. In Germany no maximum workplace concentration for sevoflurane is defined. This study aims to find out if working conditions of physicians and different anaesthesia techniques effect the extent of occupational exposure to sevoflurane.

详细描述

In this prospective observational trial 7 cohorts of 4 participants each are investigated. The cohorts consist of physicians working at different places in the operating theatre with different occupational exposure to sevoflurane, and one cohort not working in the operating theatre at all. In order to determine the extent of occupational exposure to sevoflurane a human biomonitoring is conducted. Urinary Sevoflurane and its metabolite hexafluoroisopropanol (HFIP) are measured after 3 consecutive working days.

UPDATE: After detecting traces of HFIP in all cohorts even in physicians not working in the operating theatre measurements were repeated, more cohorts were added including a negative control and measurements before the study period of 3 consecutive working days were added.

UPDATE: For comparison one cohort of patients having undergone sevoflurane anaesthesia was added.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Occupational exposure to sevoflurane while conducting sevoflurane anaesthesia/being present during sevoflurane anaesthesia
  • Possible occupational exposure to sevoflurane while working in the operating room/perioperative anaesthesia care unit
  • No occupational exposure to sevoflurane (working outside the operating theatre)

排除标准

  • Presence during a mask induction with sevoflurane

结局指标

主要结局

Urinary sevoflurane concentration (µg/l)

时间窗: After 3 consecutive days of work

After 3 consecutive days of work a urine sample is collected and urinary sevoflurane is measured by gas chromatography

Urinary HFIP concentration (µg/l)

时间窗: After 3 consecutive days of work

After 3 consecutive days of work a urine sample is collected and urinary HFIP is measured by gas chromatography

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验